KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionOpex As A % Of Total Revenue %OPEX SegregationProduct Revenue By CategoryProduct Revenue By Category AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment BreakdownPurchase And Other CommitmentsRevenue By GeographyRevenue By Geography %Revenue By Major CustomersRevenue By Major Customers %Revenue By Major Customers AnnualRevenue By Major Customers Annual %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Cost Of Revenue: 2018-2025

Historic Cost of Revenue for Dynavax Technologies (DVAX) over the last 8 years, with Sep 2025 value amounting to $14.4 million.

  • Dynavax Technologies' Cost of Revenue rose 10.08% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.6 million, marking a year-over-year increase of 24.36%. This contributed to the annual value of $49.4 million for FY2024, which is 1.44% down from last year.
  • As of Q3 2025, Dynavax Technologies' Cost of Revenue stood at $14.4 million, which was up 2.62% from $14.0 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Cost of Revenue ranged from a high of $83.4 million in Q2 2022 and a low of $8.7 million during Q4 2023.
  • For the 3-year period, Dynavax Technologies' Cost of Revenue averaged around $12.9 million, with its median value being $13.4 million (2024).
  • As far as peak fluctuations go, Dynavax Technologies' Cost of Revenue surged by 1,723.85% in 2021, and later crashed by 88.79% in 2023.
  • Over the past 5 years, Dynavax Technologies' Cost of Revenue (Quarterly) stood at $74.0 million in 2021, then grew by 4.70% to $77.5 million in 2022, then crashed by 88.79% to $8.7 million in 2023, then skyrocketed by 54.33% to $13.4 million in 2024, then rose by 10.08% to $14.4 million in 2025.
  • Its Cost of Revenue was $14.4 million in Q3 2025, compared to $14.0 million in Q2 2025 and $13.8 million in Q1 2025.